SenesTech, Inc. has developed and is in the process of commercializing a proprietary technology for managing animal pest populations, primarily rat populations, through fertility control.
Recent News
For the Health of Hospitals - At SenesTech, we love sharing stories about the successful deployment of our flagship rat contraceptive product, ContraPest. One of our triumphs this year has been reducing rat populations in a… … Read More »
The Spotlight Shines on SenesTech: Introducing our Newsletter - The Spotlight Shines SenesTech is delighted to introduce our first quarterly newsletter, which has been thoughtfully designed to keep you up to speed on company and product developments, along with… … Read More »
Are You Prepared for the California Ecosystems Protection Act? - California Awareness California residents and businesses are becoming more aware of Bill AB1788, also known as the California Ecosystems Protection Act, which will prohibit the use of second-generation anticoagulant rodenticides… … Read More »Please Note
The SenesTech Newsroom post articles are based on current SenesTech activities, developments, and news items relative to the company. These correspond to the date of publication and, as such, our team is under no obligation to update the published information. News articles are listed in chronological order and archived by year.
Looking for More Resources?
Press Releases
- SenesTech Announces Second Quarter 2019 Financial and Operational Results
- SenesTech, Inc. to Report Second Quarter 2019 Financial Results on Tuesday, August 13, 2019
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET - SenesTech Announces Closing of Public Offering of Common Stock
CEO Ken Siegel and Other Insiders Anchored the Offering by Purchasing Over $1 Million of the Offered Common Stock
Get SenesTech Updates